Adverse effects associated with the use of FK 506.

This publication has 12 references indexed in Scilit:

• Pharmacokinetics of FK 506: preclinical and clinical studies.
  1990
• Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
  1990
• Early trials with FK 506 as primary treatment in liver transplantation.
  1990
• A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
  Nature, 1989
• Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.
  1988
• The diagnosis and treatment of posttransplant lymphoproliferative disorders
  Current Problems in Surgery, 1988
• Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.
  1987
• CANCERS FOLLOWING CYCLOSPORINS THERAPY
  Transplantation, 1987
• Liver Transplantation with Use of Cyclosporin a and Prednisone
  New England Journal of Medicine, 1981
• NEPHROTOXICITY OF CYCLOSPORIN A IN LIVER AND KIDNEY TRANSPLANT PATIENTS
  The Lancet, 1981